- Investing Ideas
- Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Results
7
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
7 companies
argenx
Market Cap: €55.4b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€902.00
7D
23.5%
1Y
59.5%
UCB
Market Cap: €41.5b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€221.70
7D
4.4%
1Y
12.4%
Celyad Oncology
Market Cap: €12.6m
A biotechnology company, focuses on unlocking the potential of its intellectual property.
CYAD
€0.28
7D
3.7%
1Y
-30.3%
Hyloris Pharmaceuticals
Market Cap: €124.6m
Operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.
HYL
€4.50
7D
-0.2%
1Y
-32.8%
Financière de Tubize
Market Cap: €8.2b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€187.20
7D
2.7%
1Y
16.6%
Oxurion
Market Cap: €248.3k
A biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium.
OXUR
€0.0028
7D
7.7%
1Y
-88.8%
BioSenic
Market Cap: €1.3m
A biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.
BIOS
€0.002
7D
0%
1Y
-20.0%